Literature DB >> 23765754

Serum levels of fetuin A and 8-hydroxydeoxyguanosine in morbidly obese subjects.

S Himmetoglu1, S Teksoz, K Zengin, T Yesim, M Taskın, Y Dincer.   

Abstract

Insulin resistance is one of the feature of obesity. Fetuin A is inhibitor of insulin receptor which belongs the family of receptor tyrosine kinase. It has been observed that fetuin-null mice are resistant to diet-induced obesity and they exhibit increased insulin sensitivity. Increased production of reactive oxygen species is suggested to be associated with insulin resistance. Attacks of reactive oxygen species to DNA results in base oxidation. Among the oxidized bases, 8-hydroxydeoxyguanosine is predominant lesion with pro-mutagenic potential. In the present study; measurement of serum levels of fetuin A and 8-hydroxydeoxyguanosine in obese subjects (n=46) and healthy controls (n=22), and examination of the relations between these parameters and insulin resistance have been purposed. Blood samples were taken form morbidly obese subjects after a 12 h fasting. Serum levels of fetuin A and 8-hydroxydeoxyguanosine were measured by ELISA. Statistical analysis was performed by Mann Whitney U test and correlations were examined by Spearman correlation coefficient. Serum levels of total cholesterol, HDL, LDL, VLDL, triglycerides, free T3, free T4, fasting glucose, c-peptide and %HbA1c in the obese group were found to be different from those in the control group. Serum level of fetuin A was found to be higher, 8-hydroxydeoxyguanosine level was found to be lower in the morbid obese group than those in the control group. Fetuin A was found to be positively correlated with HOMA-IR (r:0,40, P<0.05) and negatively correlated with 8-hydroxydeoxyguanosine (r:-0,52, P<0.01). No significant association was determined between body mass index and measured parameters. In conclusion, serum level of fetuin A is high in morbidly obese subjects and is negatively associated with 8-hydroxydeoxyguanosine level in peripheral circulation. Fetuin A may be a promising link between insulin resistance and obesity as well its comorbidities. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23765754     DOI: 10.1055/s-0033-1345162

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  9 in total

Review 1.  Programming apoptosis and autophagy with novel approaches for diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

2.  DIA-Based Proteomic Analysis of Plasma Protein Profiles in Patients with Severe Acute Pancreatitis.

Authors:  He Li; Yansong Xu; Xin Zhou; Taiyang Jin; Ziru Wang; Yuansong Sun; Haiping Wang; Datong Jiang; Chunlin Yin; Bing Shen; Kai Song
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

3.  Benefits of foods supplemented with vegetable oils rich in α-linolenic, stearidonic or docosahexaenoic acid in hypertriglyceridemic subjects: a double-blind, randomized, controlled trail.

Authors:  Manja Dittrich; Gerhard Jahreis; Kristin Bothor; Carina Drechsel; Michael Kiehntopf; Matthias Blüher; Christine Dawczynski
Journal:  Eur J Nutr       Date:  2014-09-13       Impact factor: 5.614

4.  Serum levels of fetuin-A, osteoprotegerin and osteopontin in patients with coronary artery disease: effects of statin (HMGCoA-reductase inhibitor) therapy.

Authors:  Nikolaos P E Kadoglou; George Kottas; Stylianos Lampropoulos; Ioulia Vitta; Christos D Liapis
Journal:  Clin Drug Investig       Date:  2014-03       Impact factor: 2.859

Review 5.  New Insights for Oxidative Stress and Diabetes Mellitus.

Authors:  Kenneth Maiese
Journal:  Oxid Med Cell Longev       Date:  2015-05-12       Impact factor: 6.543

6.  A double blind randomized clinical trial to investigate the effect of vitamin D supplementation on metabolic and hepato-renal markers in type 2 diabetes and obesity.

Authors:  Peivasteh Safarpour; Mohammad Reza Vafa; Fatemehsadat Amiri; Leila Janani; Mitra Noorbakhsh; Ensieh Rajabpour Nikoo; Homa Sadeghi
Journal:  Med J Islam Repub Iran       Date:  2018-04-28

7.  Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial.

Authors:  Peivasteh Safarpour; Milad Daneshi-Maskooni; Mohammadreza Vafa; Mitra Nourbakhsh; Leila Janani; Mohsen Maddah; Fatemeh-Sadat Amiri; Fereshteh Mohammadi; Homa Sadeghi
Journal:  BMC Fam Pract       Date:  2020-02-07       Impact factor: 2.497

8.  Ileal transposition helps to regulate plasma hepatokine levels in obese Zucker (Crl:ZUC(ORL)-Leprfa) rats.

Authors:  Dominika Stygar; Tomasz Sawczyn; Agnieszka Dulska; Elżbieta Chełmecka; Łukasz Mielańczyk; Natalia Matysiak; Michał Kukla; Maciej Idzik; Jan Augustyniak; Andrzej Gabriel; Konrad Karcz; Jerzy Jochem
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.379

Review 9.  Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes.

Authors:  Anju Singh; Ritushree Kukreti; Luciano Saso; Shrikant Kukreti
Journal:  Molecules       Date:  2022-01-30       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.